Published in Cancer Weekly, July 26th, 2005
"The feasibility of SND for stage I primary lung cancer by VATs remains controversial. The aim of this study was to assess the feasibility of SIND by VATS," scientists in Japan reported.
"Four hundred and eleven patients with clinical stage I primary lung cancer were enrolled in this study. Two hundred and twenty-one patients, VATS group, underwent a major pulmonary resection with SIND by VATS through a mini-thoracotomy (30-70 mm) and two access ports; 190 patients, open thoracotomy (OT) group, did so through anterolateral...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.